Destination TV @ #WTM14 | Thurs 6 Nov
This event took place at #WTM14, ExCeL London on Thursday 6 November. This session looked at how powerful is the world #39;s no. 1 mass media in attracting international tourists and how can...
By: World Travel Market
View original post here:
October 17, 2014
Luxurious spa at five-star Millbrook Resort named the best of the best
The luxurious spa at Queenstowns five-star Millbrook Resort has been named the best of the best, taking out the coveted title of New Zealands Leading Spa Resort at the World Travel Awards.
Known the world over as one of the most picturesque resorts in the world, Millbrook is no stranger to winning awards, having garnered multiple accolades over the years for its five-star luxury accommodation, world-class 27-hole golf course and restaurants.
And it continues to lead the way by shrugging off stiff national competition to be named as New Zealands Leading Spa Resort. The World Travel Awards, celebrating its 21st anniversary this year, acknowledges, rewards and celebrates excellence across all sectors of the global travel and tourism industry, with half a million votes cast annually by travel professionals and high-end travellers.
Nestled in a blend of luxury and nature, The Spa at Millbrook prides itself on pampering, soothing and rejuvenating all guests during their stay, delivering only the finest, most energising experience.
Staying at Millbrook is like immersing yourself in another world -- guests can step out of their hotel room, stylish apartment or fairway home right onto the golf course. Its an easy stroll down to The Spa at Millbrook for a treatment to soothe away the stresses of busy lives.
Spa Manager Vicky Bate said it was a huge privilege to win the award.
Were delighted to have received such recognition and are very thankful for the support thats been demonstrated for this major award, she said.
Winning this award is an absolute honour and I want to thank the Millbrook Spa team for their dedication and commitment in ensuring our guests experience the magic that Millbrook offers.
Continued here:
WASHINGTON The Navy secretary has spent more than a full year of his five-year tenure on overseas travel, racking up more than 930,000 miles on trips that cost taxpayers more than $4.7 million.
Ray Mabus, the former Mississippi governor, has taken at least 40 trips outside the U.S as of July 2014, meeting officials and visiting sailors and Marines in more than 100 countries, according to data obtained and compiled by The Associated Press travel he said is critical to his job in furthering U.S. and Navy interests abroad.
The inspector general investigated after receiving a complaint about his travel and cleared him of any wrongdoing, Mabus said, but his 373 days on the road contrast with those of Army Secretary John McHugh, who took fewer than half the trips at less than half the cost over the same time period.
The travel costs come amid deep budget cuts across the Defense Department, including widespread efforts to slash headquarters spending, downsize the Army and Marine Corps, and cut back on acquisition programs, training and other costs.
Those cuts, said Bryan Clark, senior fellow at the Center for Strategic and Budgetary Assessment, make it "even more important that senior leaders scrutinize their travel and make sure that the travel they're doing is essential."
Mabus is so proud of his travel he even has a mileage ticker on his Navy website, showing he has traveled 932,129 miles as of this week. About 100,000, or one-fifth, of sailors and Marines serve in foreign posts. And, he said, negotiating issues such as basing ships in Rota, Spain, is more effective face to face.
"You could do that in a phone call, I guess. You could send them a note," he said. "I don't think they take it nearly as seriously if you're not sitting across the table from them."
He noted that a female sailor on a stop in Hawaii complained to him that she felt she had no future as a nuclear officer because women couldn't serve on nuclear submarines. That conversation, said Mabus, led to his finalizing plans to allow women to serve on the subs.
"I think the return on investment for my travel has been phenomenal," Mabus told the AP.
McHugh oversees an Army of more than 508,000 active-duty soldiers, including more than 130,000 in foreign posts. He said he tries to go where large concentrations of soldiers are as well as countries where there are national security issues.
Excerpt from:
High Speed, High Performing Super Computer
China #39;s Tianhe-2 has retained its position as the world #39;s fastest system, for the fourth time in a row. Developed by Chinese National University of Defense Technology, it offers 33.86 petaflop/s...
By: Puthiya Thalaimurai TV
Here is the original post:
By: Adam Feuerstein | 11/18/14 - 10:16 AM EST
Inject a cocktail of undifferentiated stem cellsinto a patient who has suffered a heart attack, and days or even weekslater, the stem cells transform into cardiac cells and rebuild the damaged heart muscle. Months later, the patient has a "new" healthy heart.It's a great story. But so far, the proof remains elusive though not for a lack of trying.
The latest company to fulfill this ambitious scenario is NeoStem (NBS) which presented disappointing (but not surprising) results from a small study of its proprietary cardiac stem-cell therapy NBS10 at the American Heart Association annual meeting Monday. NeoStem tried to put some positive spin on the bad news but shares are down 25% to $5.10.
NBS10, formerly known as AMR-001, is an autologous stem-cell therapy derived from a patient's own bone marrow. When injected back into patients following a heart attack, the stem cells are supposed torestore blood flow, rebuild damaged cardiac muscle and improve function.
Except in NeoStem's study, NBS10 fell short on two primary endpoints designed to assess the therapy's efficacy. The study used non-invasive imaging to assess blood flow through the heart, six months after a single infusion of NBS10 or a placebo. There was no difference between NBS and placebo, NeoStem said.
The study's other co-primary efficacy endpoint was a measurement of adverse cardiac "MACE" events --defined as cardiovascular death, a repeatheart attack, heart failure hospitalization and coronary revascularization. To date, 17% of patientstreated with NBS10 have suffered a MACE event compared to 19% of patients in the placebo arm -- a difference which was not statistically significant.
NeoStem said NBS10 therapy was safe relative to placebo and that no patients treated with the stem cells have died compared to three deaths in the placebo patients. But with only one year of follow up on a small number of patients, any claims about a mortality benefit are clinically meaningless.
Originally posted here:
NeoStem's Stem Cell Therapy Fails Mid-Stage Heart Attack Study
Researchers at the Cedars-Sinai Heart Institute have found that injections of cardiac stem cells might help reverse heart damage caused by Duchenne muscular dystrophy, potentially resulting in a longer life expectancy for patients with the chronic muscle-wasting disease.
The study results were presented today at a Breaking Basic Science presentation during the American Heart Association Scientific Sessions in Chicago. After laboratory mice with Duchenne muscular dystrophy were infused with cardiac stem cells, the mice showed steady, marked improvement in heart function and increased exercise capacity.
Duchenne muscular dystrophy, which affects 1 in 3,600 boys, is a neuromuscular disease caused by a shortage of a protein called dystrophin, leading to progressive muscle weakness. Most Duchenne patients lose their ability to walk by age 12. Average life expectancy is about 25. The cause of death often is heart failure because the dystrophin deficiency leads to cardiomyopathy, a weakness of the heart muscle that makes the heart less able to pump blood and maintain a regular rhythm.
"Most research into treatments for Duchenne muscular dystrophy patients has focused on the skeletal muscle aspects of the disease, but more often than not, the cause of death has been the heart failure that affects Duchenne patients," said Eduardo Marbn, MD, PhD, director of the Cedars-Sinai Heart Institute and study leader. "Currently, there is no treatment to address the loss of functional heart muscle in these patients."
During the past five years, the Cedars-Sinai Heart Institute has become a world leader in studying the use of stem cells to regenerate heart muscle in patients who have had heart attacks. In 2009, Marbn and his team completed the world's first procedure in which a patient's own heart tissue was used to grow specialized heart stem cells. The specialized cells were then injected back into the patient's heart in an effort to repair and regrow healthy muscle in a heart that had been injured by a heart attack. Results, published in The Lancet in 2012, showed that one year after receiving the experimental stem cell treatment, heart attack patients demonstrated a significant reduction in the size of the scar left on the heart muscle.
Earlier this year, Heart Institute researchers began a new study, called ALLSTAR, in which heart attack patients are being infused with allogeneic stem cells, which are derived from donor-quality hearts.
Recently, the Heart Institute opened the nation's first Regenerative Medicine Clinic, designed to match heart and vascular disease patients with appropriate stem cell clinical trials being conducted at Cedars-Sinai and other institutions.
"We are committed to thoroughly investigating whether stem cells could repair heart damage caused by Duchenne muscular dystrophy," Marbn said.
In the study, 78 lab mice were injected with cardiac stem cells. Over the next three months, the lab mice demonstrated improved pumping ability and exercise capacity in addition to a reduction in heart inflammation. The researchers also discovered that the stem cells work indirectly, by secreting tiny fat droplets called exosomes. The exosomes, when purified and administered alone, reproduce the key benefits of the cardiac stem cells.
Marbn said the procedure could be ready for testing in human clinical studies as soon as next year. The process to grow cardiac-derived stem cells was developed by Marbn when he was on the faculty of Johns Hopkins University. Johns Hopkins has filed for a patent on that intellectual property and has licensed it to Capricor, a company in which Cedars-Sinai and Marbn have a financial interest. Capricor is providing funds for the ALLSTAR clinical trial at Cedars-Sinai.
Read more from the original source:
Cardiac stem cell therapy may heal heart damage caused by Duchenne muscular dystrophy
NEW YORK (TheStreet) -- Shares ofNeoStem (NBS) plummeted 25.52% to $5.05 in late morning trading Tuesdayafter the biotech company announced poor results from a trial of its proprietary cardiac stem-cell therapy NBS10.
NBS10, which used to be called AMR-001, missed two primary endpoints in the study to test the therapy's efficacy.The stem-cell therapy comesfrom a patient's own bone marrow and is injected into patients after a heart attack. The stem cells are then supposed to help blood flow and build cardiac muscle.
NeoStem's trial used non-invasive imaging to monitor blood flow through the heart six months after a one dose of NBS10 or a placebo. The study showed no difference between NBS and placebo, NeoStem said.
Must Read:NeoStem's Stem Cell Therapy Fails Mid-Stage Heart Attack Study
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Jim Cramer's protg, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Continued here:
NeoStem (NBS) Stock Plummets Today on Disappointing Cardiac Stem-Cell Therapy Data
In Search of the Absolute: DMT and Spirituality with Martin Ball ph.D
In Search of the Absolute: DMT and Spirituality with Martin Ball ph.D In this installment, author, artist and entheogenic explorer Martin Ball ph.D joins us to discuss 5meo - DMT and the experience...
By: Free Radical Media
Read more from the original source:
In Search of the Absolute: DMT and Spirituality with Martin Ball ph.D - Video
Lets Play Lego Batman 3 - Hide N #39; Seek Grundy Killer Croc (Pt 7 BEYOND GOTHAM) Space Station END
Here is the end of Space Station Infestation! We get Electricity Suit Batman, we use Superman, we defeat Mech-Suit Lex Luthor and Joker and a bunch of other fun things go down like Hide and...
By: FGTeeV
See the article here:
Earth From Space: Video From the International Space Station: Snow Patrol chasing cars : Space Video
View the earth as seen from space with footage taken from the ISS. Sit back and relax. This version of "Chasing Cars": Star Music catalog licensed by any.TV for commercial purposes for all...
By: Amazing Space
Originally posted here:
Blue Dot mission summary
ESA astronaut Alexander Gerst spent 166 days in space with NASA astronaut Reid Wiseman and Roscosmos commander Max Suraev in 2014. This ten-minute video shows highlights of his Blue Dot ...
By: European Space Agency, ESA
Original post:
Ottobar Space Party Preview
#39;SPACE JAM #39; - A DANCE PARTY ODYSSEY! - 11.22.14 This dance party odyssey will feature a special screening of "Interstella 5555: The 5tory of the 5ecret 5tar 5ystem", an animated film set to...
By: Ryan Shannahan
Visit link:
Space Station 3D Printer Readied For Test Prints | Video
The Made In Space printer was launched aboard the SpaceX CRS-4 mission in Sep. 2014. On Nov. 17th, 2014, the printer was installed into the microgravity science laboratory #39;s glove box. Its...
By: VideoFromSpace
See the article here:
Space Station 3D Printer Readied For Test Prints | Video - Video
LEGO Batman 3: Beyond Gotham - Need for Greed - Part 16 (Xbox One Gameplay)
The Asian Guy Gamer and The Asian Kid Gamer are playing LEGO Batman 3: Beyond Gotham on the Xbox One!!! Be sure to hit the "LIKE" button for more LEGO Batman 3: Beyond Gotham!!! LEGO ...
By: The8Bittheater
View post:
LEGO Batman 3: Beyond Gotham - Need for Greed - Part 16 (Xbox One Gameplay) - Video
NORAD Tracks Santa 2002 - International Space Station/Pyramids
NOTE *: UPLOADING THIS VIDEO NOW, AS I JUST DISCOVERED IT WAS MISSED WHEN I ORIGINALLY UPLOADED THE 2002 VIDEOS FIVE YEARS AGO. I WILL BE ADDING THIS VIDEO TO THE ...
By: elezb101
Read the original:
NORAD Tracks Santa 2002 - International Space Station/Pyramids - Video
#We Need Space
I asked my community How will space, science, and technology benefit humanity? With over 30 phenomenal responses, Yoguely proudly presents #WeNeedSpace. I would like to thank everyone...
By: Yoguely
Read this article:
Futura mission
On 23 November, Samantha Cristoforetti will fly to the International Space Station on board a Soyuz from Baikonur Cosmodrome. Selected as an ESA astronaut in May 2009, Samantha Cristoforetti...
By: European Space Agency, ESA
More:
3 Floyds Brewery - Space Station Middle Finger Pale Ale
Munster, Indiana.
By: Beer Sampling With Dave
Go here to see the original:
3 Floyds Brewery - Space Station Middle Finger Pale Ale - Video
First Italian Woman Prepares to Fly in Space
Italian astronaut Samantha Cristoforetti prepares for her upcoming mission to fly to the International Space Station (ISS) aboard a Soyuz capsule from Baikonur, Kazakhstan on November 24. ...
By: NTDTV
The rest is here:
WASHINGTON, Nov. 18 (UPI) -- The International Space Station is now home to a 3-D printer, after NASA astronaut Barry Wilmore spent most of Monday unpacking and installing the machine. He and his colleagues will soon begin experimenting with additive manufacturing in microgravity.
The printer was engineered by the California-based company Made In Space and delivered to the space station in late September, but its installation had to be put off while astronauts wrapped up a few time-sensitive experiments.
If the new printer works properly in space, it could help ISS astronauts become more self-sufficient -- allowing them to design and print their own tools and gadgets right on board instead of waiting for another resupply cargo ship to be launched from Earth.
To ensure the printer is unaffected by microgravity, astronauts will begin by printing a pair of "engineering coupons." The coupons will be sent back to mission control where they'll be compared to coupons that were printed before the machine was packaged and shipped into outer space.
"This is a very exciting day for me and the rest of the team. We had to conquer many technical challenges to get the 3D printer to this stage," Made In Space lead engineer Mike Snyder said in a company press release. "This experiment has been an advantageous first stepping stone to the future ability to manufacture a large portion of materials and equipment in space that has been traditionally launched from Earth surface, which will completely change our methods of exploration."
Snyder and his colleagues are confident in their work and expect the machine to perform as advertised.
"We have really high expectations for it printing," Jason Dunn, the company's chief technology officer, said in an interview earlier this year. "We've done all the zero gravity research we could on the airplane. (But) there's always the things we can't test that you can only do once you're up there."
2014 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
More here: